New drug shows promise for bulging eyes in thyroid disease
NCT ID NCT06525506
First seen Nov 01, 2025 · Last updated Jun 13, 2026 · Updated 31 times
Summary
This study tested a new drug called IBI311 in 38 people with thyroid eye disease, a condition that can cause bulging eyes and discomfort. Participants received different doses of the drug to see if it could reduce eye bulging and improve symptoms. The goal was to find the best dose that is both safe and effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID EYE DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Innovent Biologics (Suzhou) Co. Ltd
Suzhou, Suzhou, 215123, China
Conditions
Explore the condition pages connected to this study.